NCT03309462View on ClinicalTrials.gov

Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

July 31, 2019

Conditions
Lung Cancer
Interventions
DEVICE

Miseq sequencer

The sequencer will be used to detect the gene mutations of the re-biopsy tissue samples and peripheral blood samples obtained from patients.

Trial Locations (1)

200030

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Chest Hospital

OTHER

NCT03309462 - Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy | Biotech Hunter | Biotech Hunter